氯法齐明与贝达喹啉的作用机制及治疗疗效
耐药结核病是全球结核病控制的重大挑战,常需使用疗效有限二线药物。本文综述了氯法齐明与贝达喹啉这两种亲脂性抗分枝杆菌药物的分子作用机制、对静息和代谢活跃菌的靶向、耐药结核病临床疗效、耐药机制、药效学、药代动力学及不良事件等方面的异同。
要点
- 氯法齐明与贝达喹啉均为亲脂性阳离子两亲性药物,可靶向外膜离子转运体。
- 贝达喹啉主要靶点为F1/F0-ATP酶,氯法齐明靶点较不选择性。
- 氯法齐明耐药水平极低,可能与其多靶点作用有关。
核心结论
- 氯法齐明与贝达喹啉虽结构不同,但均通过阳离子两亲性靶向外膜离子转运体发挥抗分枝杆菌作用。
- 贝达喹啉主要抑制F1/F0-ATP酶,氯法齐明靶点较不选择性,可能解释其极低耐药水平。
研究设计与样本
- 综述,聚焦氯法齐明与贝达喹啉的异同。
主要发现
- 两者均为亲脂性阳离子两亲性药物,可靶向并灭活结核分枝杆菌外膜关键离子转运体。
- 贝达喹啉主要靶点为呼吸链关键酶F1/F0-ATP酶。
- 氯法齐明选择性较低,似乎抑制多个靶点,可能与其极低耐药水平有关。
临床怎么用
- 氯法齐明和贝达喹啉可用于耐药结核病治疗,两者均属第5组抗生素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug-resistant (DR)-TB is the major challenge confronting the global TB control programme, necessitating treatment with second-line anti-TB drugs, often with limited therapeutic efficacy. This scenario has resulted in the inclusion of Group 5 antibiotics in various therapeutic regimens, two of which promise to impact significantly on the outcome of the therapy of DR-TB. These are the 're-purposed' riminophenazine, clofazimine, and the recently approved diarylquinoline, bedaquiline. Although they differ structurally, both of these lipophilic agents possess cationic amphiphilic properties that enable them to target and inactivate essential ion transporters in the outer membrane of Mycobacterium tuberculosis. In the case of bedaquiline, the primary target is the key respiratory chain enzyme F1/F0-ATPase, whereas clofazimine is less selective, apparently inhibiting several targets, which may underpin the extremely low level of resistance to this agent. This review is focused on similarities and differences between clofazimine and bedaquiline, specifically in respect of molecular mechanisms of antimycobacterial action, targeting of quiescent and metabolically active organisms, therapeutic efficacy in the clinical setting of DR-TB, resistance mechanisms, pharmacodynamics, pharmacokinetics and adverse events.
引用
- Cholo MC, Mothiba MT, Fourie B, et al. Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline. J Antimicrob Chemother. 2016. PMID: 27798208. doi:10.1093/jac/dkw426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。